Neuroblastoma originating from neural crest is the most common extracranial solid tumor of childhood. A recent report from Denmark showed that one in 7000 live births might develop neuroblastoma before age 15 y (1) . Neuroblastomas in patients less than 1 y old tend to differentiate and regress spontaneously, and even in disseminated diseases with liver, skin, or bone marrow metastasis, designated as stage 4S, they may regress completely (1, 2) . The mechanism of spontaneous differentiation and regression of the neuroblastomas remains to be determined. The evidence that neuroblastoma cells in vitro differentiate into more mature ganglion cells or neuroepithelial cells in response to differentiation agents such as RA (3) and nerve growth factor (4) indicates that some intrinsic factors may be directly or indirectly implicated in the differentiation resulting in regression.
RA derived from vitamin A or p-carotene is an important endogenous compound that regulates embryogenesis and vertebrate development (5, 6) . Several clinical trials have been used to identify effects of RA on tumor differentiation therapy. cRA has shown effectiveness in the treatment of premalignancies such as oral leukoplakia lesion and laryngeal papillomatosis (7, 8) . cRA, however, showed no significant effectiveness in the treatment of solid tumors or acute nonlymphocytic leukemia (9, 10) . Recently, tRA has been shown to effectively induce complete remission of acute promyelocytic leukemia without showing disseminated intravascular coagulopathy ( 1 1, 12), a serious complication commonly seen in the acute promyelocytic leukemia induction therapy (13) . Sidell et al. (3) and Pahlman et al. (14) showed that tRA could cause neuroblastoma cell differentiation to neuron-like or perineurium-like cells depending on different neuroblastoma cell lines tested. These results suggest that tRA may be involved in the spontaneous differentiation and regression of neuroblastoma cells.
Patients with a lower grade of neuroblastoma tend to have a RA, retinoic acid better prognosis (1, 15) ; Evidence has also shown that more TNFa, tumor necrosis factor-a differentiated neuroblastomas were more frequently associated GM-CSF, granulocyte-macrophage colony stimulating fac-with leukocyte infiltration (16). These data suggest that the tor prognosis of patients with a neuroblastoma may depend not only cRA, 134s-RA on differentiation of tumor cells, but also possibly on differentiatRA, all-trans-RA tion-associated leukocyte infiltration. RA, which can enhance neuroblastoma cell differentiation (3, 4) , has shown effectiveness in regulating tumor-infiltrating leukocytes (17) and modulating leukocyte functions (18) . In an attempt to clarify whether induction of neuroblastoma cell differentiation by RA was associated with expression of leukocyte-activating or chemotactic factors, NEUROBLASTOMA CELL DIFFERENTIA TION AND LEUKOCYTE CHEMOTAXIS 72 1
MATERIALS AND METHODS
Culture and drfferentiation of neuroblastoma cells. Human neuroblastoma cells, SK-N-SH (American Type Culture Collection, Rockville, MD), were regularly cultured in Eagle's minimal essential medium (Gibco Co., Grand Island, NY) supplemented with 10% FCS, 1 mM glutamine, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, gentamicin (50 pg/mL), and penicillin (100 pg/mL) at a density of 1 x 10' cells/mL in a 5% C02-humidified incubator at 37'C and harvested using 0.02% EDTA in PBS. Differentiation of neuroblastoma cells induced by tRA (Sigma Co., St. Louis, MO) was determined by the change of morphology from tear-drop-shaped neuroblasts to epitheloid perineurium-like cells, decrease of tumor cell proliferation, cell-cycle arrest in Go/Gl phase, and down-regulation of N-myc gene expression.
Assessment of tumor cell proliferation and cell-cycle proportion. Assessment of tumor cell proliferation was performed by a 'Hthymidine (ICN Radiochemicals, Irvine, CA) incorporation assay (19) . Neuroblastoma cells (5 x lo4 cells/mL, 200 pL) were put in microtiter wells and treated with RA ( I pM) or vehicle alone for 2 d before 1 pCi of 'H-thymidine was added to each well. After an additional 5 h of incubation, cells were harvested and counted by a p-counter. Analysis of cell-cycle proportion in differentiated and undifferentiated cells was determined by a flow cytometric analysis of DNA content indicated by propidium iodide staining.
Detection of cytokine mRNA expression. Total cellular RNA from neuroblastoma cells was purified by the guanidine isothiocyanate-cesium chloride method (20) . Total RNA was subjected to electrophoresis in 1 % agarose-formaldehyde gels, transferred to nitrocellulose filters, and hybridized to one of the following '2P-labeled cDNA probes: the 5.4-kb Hind111 insert of human GM-CSF cDNA, the 1.0-kb BamHI/EcoRI insert of N-myc cDNA (American Type Culture Collection), the 0.6-kb BamHIl SmaI insert of human IL-I@ cDNA, the I . 1-kb PstI insert of human TNFa cDNA, the 0.6-kb EcoRI insert of human IL-8 cDNA, and the 2.0-kb PstI insert of chicken P-actin gene (19) . Hybridizations were carried out at 42°C for 16 h in 50% (vol/ vol) formamide, 2 x SSC (1 x SSC = 0.15 M sodium chloride and 0.015 M sodium citrate), 1 x Denhardt's solution, 0.1 % SDS, and 200 pg/mL salmon sperm DNA (20) . Filters were washed in 2 x SSC-0. 1 % SDS and 0. I x SSC-0. I % SDS twice before being exposed to Kodak X-OMAT x-ray film. Results of mRNA expression were quantified by a densitometer (X-Ograph Ltd., Malmesbury, England).
Detection of IL-8. IL-8 levels were measured by ELISA. ELISA kits for IL-8 determination were purchased from Quantikine (R & D Systems Inc., Minneapolis, MN). Values were based on interpolation from a standard curve generated by samples of known concentration provided with each ELISA kit (19) .
Neutrophil and lymphocyte chemotaxis. Neutrophils and lymphocytes were prepared as previously described (2 1). Studies of leukocyte chemotaxis were performed in the multiwell modified Boyden chambers (21). Lower chambers were filled with 25 pL of culture supernatants from tRA-treated and untreated neuroblastoma cells or with recombinant IL-8 (0.1 to 10 ng/mL; Genzyme Corp., Cambridge, MA) in the presence or absence of anti-IL-8 neutralizing antibody, which has an ability to neutralize 2-10 ng/mL human IL-8 at a 1:10000 dilution (Upstate Biotechnology, Lake Placid, NY). Upper chambers were filled with 50 pL of neutrophils or lymphocytes (2 x lo6 cells/mL). Nitrocellulose membranes that have a relatively small pore size (5 pm) and are thick (Millipore Corp., Bedford, MA) were layered between upper and lower chambers for neutrophil chemotaxis. Polycarbonate membranes that have a relatively large pore size (8 pm) and are thin (Nucleopore Co., Pleasanton, CA) were used for lymphocyte chemotaxis. Reactions were carried out in a humidified incubator at 37°C for 120 min. After incubation, filters were fixed in methanol and stained with hematoxylin. Neutrophils or lymphocytes migrating completely through the filter were viewed in a 400x microscope field. Leukocytes in five random fields were counted. Each experiment included triplicate samples and was reproduced three times. (Fig. 2A) . In addition, tRA ( I . O /.iM) markedly suppressed neuroblastoma cell proliferation as determined by a 'H-thymidine incorporation assay (Fig. 2B) . Using flow cytometric analysis of cell-cycle proportion of neuroblastoma cells, we found that tRA induced cell-cycle arrest, with 91.2% of RA-treated cells in the GoIGI phase compared with 75.7% of the untreated cells (Fig. 28) . These results indicated that tRA could effectively induce differentiation of SK-N-SH neuroblastoma cells.
RESULTS

Induction
Induction of IL-lp, IL-8, GM-CSF, and TNFa mRNA by IRA. SK-N-SH cells did not constitutionally express IL-10, IL-8, GM-CSF, or TNFa mRNA. IL-lp, GM-CSF, and TNFa mRNA were also not detectable in the SK-N-SH cells exposed to tRA (1.0 pM) for 1, 2, 3, and 5 d, whereas IL-8 mRNA was expressed by the RA-treated SK-N-SH cells in 1 d. The induction of IL-8 mRNA expression by tRA (1.0 pM) was time dependent, being minimally detectable at 6 h of incubation, maximally detectable at 24 h, and down-regulated after 72 h (Fig. 3A) . Coculture of SK-H-SH cells with vehicle (0.02% ethanol) did not express IL-8 mRNA during this culture period. As demonstrated in Figure  3B , expression of IL-8 mRNA in neuroblastoma cells treated with tRA for 24 h was concentration dependent, having a maximal IL-8 mRNA induction with the tRA concentration at 1.0 pM. A lower tRA concentration (less than 0.1 pM) or a higher tRA concentration (5.0 pM) induced much less IL-8 mRNA expression in the neuroblastoma cells than the 1.0 pM concentration (Fig. 3B) . When given serial dilutions of the total RNA obtained from the neuroblastoma cells treated by 1.0 pM tRA (25 pg) extracted from these cells was tested by I% agarose gel electrophoresis and hybridized to "P-labeled N-myc and @-actin cDNA probes (A). Density of N-myc and @-actin mRNA expression was quantitated by a densitometer and shown as arbitrary units. Results of cell proliferation calculated from three triplicate experiments (mean cpm + SEM) were assessed by 'Hthymidine incorporation. Cell-cycle proportion data (5%) were calculated from two duplicate experiments with flow cytometric analysis of propidium iodide staining (B).
for 24 h, expression of IL-8 mRNA was detectable even in a very low concentration of total RNA (2.0 pg; 1 to 12.5 dilution) loaded for the study, and the density of IL-8 mRNA expression was proponionally correlated to the concentration of total RNA loaded (Fig. 4) .
Production of IL-8 by neuroblastoma cells stimulated with tRA. TO determine whether the expression of IL-8 mRNA by SK-H-SH cells was associated with secretion of IL-8, we used ELISA to detect IL-8 levels in the culture supernatants from tRA-treated and untreated SK-H-SH cells. Results (mean f SEM) calculated from three duplicate experiments showed that neuroblastoma cells cultured with tRA (1.0 pM) for 3 d secreted high levels of IL-8 (2.65 i 0.43 ng/mL), whereas neuroblastoma cells cultured in vehicle (0.02% ethanol) alone did not produce a significant amount of IL-8 (0.05 f 0.04 ng/mL).
Dlferentiated neuroblastoma cell-mediated neutrophil and lymphocyte chemotaxis. IL-8 is well known to induce neutrophil and lymphocyte chemotaxis. Experiments were next performed to determine whether the IL-8-containing culture supernatants from RA-treated neuroblastoma cells caused neutrophil and lymphocyte chemotaxis. As shown in Figure 5 , recombinant IL-8 at 10 ng/mL effectively induced neutrophil chemotaxis. Culture supernatants from RA-treated neuroblastoma cells could significantly induce chemotaxis of neutrophils and lymphocytes, whereas supernatants from untreated neuroblastoma cells or culture medium containing 1 pM RA had no effect on neutrophil and lymphocyte chemotaxis. An anti-IL-8 neutralizing antibody at a (vol/vol) concentration of 1:200, which could effectively block recombinant IL-8-induced neutrophil chemotaxis, significantly inhibited the RA enhancement of differentiated neuroblastoma cell-mediated neutrophil and lymphocyte chemotaxis (Fig. 5) . These results suggest that RA-induced neuroblastoma cell differentiation is associated with functional IL-8 secretion.
DISCUSSION
Cytokines from the immune system can regulate functions of the CNS (22) . Recently, evidence has also shown that neuronal and perineureal cells in the CNS can elaborate cytokines to affect immune functions (23, 24) . Human astrocytes were also able to produce IL-IS (23) , and glioblastoma cells could release many kinds of cytokines such as IL-1@, IL-6, TNFa, GM-CSF, and transforming growth factor-@ (22) (23) (24) . Furthermore, transforming growth factor-@ from glioblastomas has been proposed to have a potential link to Candida meningitis (25) . The relationship between the peripheral nervous system and leukocytes remains to be determined. Using a neuroblastoma cell line, SK-N-SH, we found that undifferentiated neuroblastoma cells did not express cytokines such as IL-I@, TNFa, GM-CSF, or IL-8, whereas RA-induced differentiated neuroblastoma cells released functional IL-8 that could effectively induce lymphocyte and neutrophi1 chemotaxis. The amino acid sequence of IL-8 has a striking similarity with some transforming-related factors such as 9E3 and gro as well as cytokine-related proteins such as interferon-7 inducible protein (IP 107) and platelet factor 4 (26). Whether IL-8 acts a growth factor, motility factor, or neural differentiation factor for neuroblastoma cells and their embryonic neural crest cells remains to be determined. RA, derived from vitamin A or @-carotene, has been shown in virro to induce differentiation of neuroblastoma cells (3, 4) and to regulate tumor-infiltrating leukocytes in an animal model (1 7). Data from clinical and epidemiologic studies on neuroblastomas have indicated that young patients (less than 1 y old) with a lower grade of tumor cells have a better outcome (1, 15) . In addition. Martin and Beckwith (16) re~orted that the more present study indicated that RA-treated, but not untreated, neuroblastoma cells expressed IL-8 mRNA and released functional IL-8 capable of attracting neutrophils and lymphocytes. Furthermore, we found that phorbol ester (32 nM), a potent neuroblastoma cell differentiation inducer, could also induce prominent IL-8 expression in SK-N-SH neuroblastoma cells (data not shown). Taken together, these in vitro studies suggest that spontaneous regression of neuroblastomas may involve not only tumor cell differentiation, but also differentiation-associated immune responses. To test this hypothesis in vivo, additional studies with sequentially histologic and in situ IL-8 hybridization examinations of neuroblastoma specimens from patients under RA treatment are needed.
Randomized clinical trials of tRA treatment for neuroblastomas are ongoing (28) . Some early phase trials using cRA showed partial effectiveness in reducing tumor content (28) or no significant effect in the treatment for advanced neuroblastomas when given as a single daily dose (29) . The fact that RA given as a single agent could not induce terminal differentiation in all neuroblastomas in vivo was not unexpected, inasmuch as RAresistant neuroblastoma cell lines have been reported and most of the cultured neuroblastoma cells regain their growing ability after RA is removed from the medium (301. However. RA alone or in combination with other chemothkra;>eutic or antiproliferative agents may be beneficial in promoting terminal differentiation and preventing recurrence of neurobiastomas, presumably through its enhancement of cellular immunity, IL-2-induced lymphokine-activated killer cell function, and NK cell activity (17, 18, 28) or its promotion of differentiation-associated leukocyte responses, as shown in the present study.
